Atlas Trials

Implication of Metformin Plus Aromatase Inhibitor in Obese Postmenopausal Breast Cancer Women

Clinical trial NCT05053841 · COMPLETED

Trial details

NCT number
NCT05053841
Sponsor
Tanta University
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
MetforminBreast Cancer
Start date
2014-02-01
Primary completion
2015-06-01
Enrollment
45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.